Results 251 to 260 of about 119,702 (338)

α-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal Parkinson Disease. [PDF]

Neurology
Coughlin DG, Shifflett B, Farris CM, Ma Y, Galasko D, Edland SD, Mollenhauer B, Brumm MC, Poston KL, Marek K, Siderowf AD, Soto C, Concha-Marambio L, as the Investigators of the Parkinson's Progression Marker Initiative.   +13 more
europepmc   +1 more source

Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease

Annals of Neurology, EarlyView.
Objective Although dopamine transporter (DaT) imaging is a valuable diagnostic biomarker, few studies have investigated its utility in objectively monitoring disease progression in patients with Parkinson's disease (PD). To date, no study has established a longitudinal relationship between the DaT signal decline and the motor symptom increase ...
Verena Dzialas, Gérard N. Bischof, Kathrin Möllenhoff, Alexander Drzezga, Thilo van Eimeren   +4 more
wiley   +1 more source

AI in Neurology: Everything, Everywhere, All at Once Part 3: Surveillance, Synthesis, Simulation, and Systems

Annals of Neurology, EarlyView.
This final part 3 review builds on the practical applications discussed in part 2 and explores how artificial intelligence (AI) is transforming data management, neurological education, and neurological care across large healthcare networks and datasets. The review also highlights AI's role in real‐world and synthetic data, digital twins, and innovative
Matthew Rizzo
wiley   +1 more source

Prevalence, distribution and future projections of Parkinson disease in Brazil: insights from the ELSI-Brazil cohort study. [PDF]

Lancet Reg Health Am
Schlickmann TH, Tessari MS, Borelli WV, Marconi GA, Pereira GM, Zimmer E, Noyce A, Mata IF, de Mello Rieder CR, Teixeira-Dos-Santos D, Schumacher Schuh AF.   +10 more
europepmc   +1 more source

Expression Patterns of Retinoblastoma Protein in Parkinson Disease

, 2003
Kelly L. Jordan‐Sciutto, Robert E. Dorsey, Elisabeth Mole Chalovich, Robert Hammond, Cristian L. Achim   +4 more
openalex   +1 more source

Cholinergic Degeneration and Cognitive Function in Early GBA1‐Related Parkinson's Disease

Annals of Neurology, EarlyView.
Objective The phenotype of patients with Parkinson's disease carrying GBA1 variants (GBA‐PD) suggest similarities to symptomatology associated with early cholinergic system degeneration. Therefore, this study aims to investigate the clinical features and the cholinergic innervation pattern in patients with early GBA‐PD versus those without the GBA1 ...
Sofie Slingerland, Sygrid van der Zee, Giulia Carli, Anne C. Slomp, Emile d'Angremont, Jeffrey M. Boertien, Teus van Laar   +6 more
wiley   +1 more source

Long-Term Dementia Risk in Parkinson Disease. [PDF]

Neurology
Gallagher J, Gochanour C, Caspell-Garcia C, Dobkin RD, Aarsland D, Alcalay RN, Barrett MJ, Chahine L, Chen-Plotkin AS, Coffey CS, Dahodwala N, Eberling JL, Espay AJ, Leverenz JB, Litvan I, Mamikonyan E, Morley J, Richard IH, Rosenthal L, Siderowf AD, Simuni T, York MK, Willis AW, Xie SX, Weintraub D, Parkinson's Progression Markers Initiative.   +25 more
europepmc   +1 more source

Interaction Between Traffic-Related Air Pollution and Parkinson Disease Polygenic Risk Score.

JAMA Netw Open
Kwon D, Paul KC, Kusters C, Wu J, Bronstein JM, Lill CM, Ketzel M, Raachou-Nielsen O, Hansen J, Ritz B.   +9 more
europepmc   +1 more source

Enhancing parkinson disease detection through feature based deep learning with autoencoders and neural networks. [PDF]

Sci Rep
Valarmathi P, Suganya Y, Saranya KR, Shanmuga Priya S.   +3 more
europepmc   +1 more source

Correction to "The Prevalence of Parkinson Disease in Ukraine". [PDF]

Mov Disord Clin Pract
europepmc   +1 more source